Version 1 of 34 (2008-04-09 to 2008-07-02) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Organization: |
The Arthritis Society / La Société d'Arthrite
393 University Ave, Ste 1700 Toronto, ON M5G 1E6 Canada |
||||
Telephone number: | 416-979-3353 Ext.: 366 | ||||
Fax number: | |||||
Responsible officer name and position during the period of this registration: | Steven McNair, President and CEO | ||||
Description of the organization's activities: | A national charity, with divisions in each province/territory, that provides expertise, research and career development and services on arthritis for the people of Canada | ||||
Organization's membership or classes of membership: | The corporate members are the members of the national and divisional boards | ||||
Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | Yes | ||||
End date of the organization's last completed financial year: | 2007-03-31 | ||||
|
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Finance Canada (FIN), Health Canada (HC), Members of the House of Commons, National Research Council (NRC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Revenue Canada (RC), Senate of Canada, Social Sciences and Humanities Research Council (SSHRC), Statistics Canada (StatCan) | ||||||||||||||||
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||||||||||
Subject Matter: Areas of Concern: | Aboriginal Affairs, Employment and Training, Health, Science and Technology, Taxation and Finance | ||||||||||||||||
Subject Matter: Retrospective: | none | ||||||||||||||||
Subject Matter: Prospective: | Arthritis as a major chronic disease and a priority for chronic disease management and prevention strategies and activities, Indirect Costs of Research Program, pharmaceutical policy and access to perscription medications, joint replacement wait time benchmarks | ||||||||||||||||
Details Regarding the Identified Subject Matter
|